Literature DB >> 4185041

Quantitative studies of the specificity of anti-pneumococcal antibodies, types 3 and 8. IV. Binding of labeled hexasaccharides derived from S3 by anti-S3 antibodies and their Fab fragments.

M Katz, A M Papenheimer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4185041

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  7 in total

1.  Rabbit antibodies to the cell wall polysaccharide of Streptococcus pneumoniae fail to protect mice from lethal challenge with encapsulated pneumococci.

Authors:  S C Szu; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

2.  T lymphocyte function as the principal target of lymphocytic choriomeningitis virus-induced immunosuppression.

Authors:  K Bro-Jorgensen; F Güttler; P N Jorgensen; M Volkert
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 3.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

4.  Studies on immunological paralysis. V. The influence of molecular weight on the immunogenicity, tolerogenicity and antibody-neutralizing activity of the 3 pneumococcal polysaccharide.

Authors:  J G Howard; H Zola; G H Christie; B M Courtenay
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

5.  Rabbit lymphoid cells. II. Anti-allotype antisera, lipopolysaccharide and other bacterial and fungal mitogens as probes for the identification of B-cell subpopulations.

Authors:  P N Shek; C T Chou; S Dubiski; B Cinader
Journal:  Immunology       Date:  1976-07       Impact factor: 7.397

6.  Characterization of the Salmonella paratyphi C Vi polysaccharide.

Authors:  E M Daniels; R Schneerson; W M Egan; S C Szu; J B Robbins
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

7.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.